Circulation

MARCH 31, 2024

Circulation, Volume 149, Issue 14 , Page 1059-1061, April 2, 2024.

Sudden Cardiac Death 45

Sudden Cardiac Death Defibrillator Circulation 45

HeartRhythm

APRIL 30, 2024

ß-blockers and flecainide have been used for treatment of VT as were implantable cardioverter defibrillators (ICD) for prevention of sudden cardiac death (SCD).

Sudden Cardiac Death 40

Sudden Cardiac Death Defibrillator 40

Open Heart

MARCH 8, 2024

The wearable cardioverter defibrillator (WCD) is becoming a more and more widely used instrument for the prevention of sudden cardiac death of patients either with a secondary prevention implantable cardioverter defibrillator indication or with a transient high risk of sudden cardiac death.

Sudden Cardiac Death 52

Sudden Cardiac Death Defibrillator Atrial Fibrillation Arrhythmia 52

Open Heart

SEPTEMBER 18, 2024

Introduction Wearable cardioverter-defibrillators (WCD) have emerged as a valuable tool in the management of patients at risk for life-threatening arrhythmias. These devices offer a non-invasive and temporary solution, providing continuous monitoring and the potential for prompt defibrillation when needed.

Defibrillator 52

Defibrillator Sudden Cardiac Death Arrhythmia Outpatient 52

Medical Xpress - Cardiology

OCTOBER 31, 2024

New research published in the European Heart Journal shows that it is extremely difficult to predict with accuracy among patients who have had a heart attack those who will go on to suffer a sudden cardiac death, even among those with a left ventricular ejection fraction (LVEF) of 35% or lower—commonly used as a justification for prophylactic defibrillator (..)

Sudden Cardiac Death 40

Sudden Cardiac Death Heart Attack Heart attacks Research 40

All About Cardiovascular System and Disorders

MARCH 17, 2024

Here is the transcript of the video: Implantable defibrillator is an important life saving device. Then, why is it mentioned that, implanting a defibrillator soon after an acute myocardial infarction, in those with left ventricular dysfunction and prone for ventricular arrhythmias and sudden cardiac death, is not useful?

Myocardial Infarction 52

Myocardial Infarction Defibrillator Sudden Cardiac Death Arrhythmia 52

HeartRhythm

NOVEMBER 27, 2024

Despite an elevated risk of sudden cardiac death among dialysis patients, implantable cardioverter defibrillators (ICDs) have not been shown to improve mortality and are associated with high complication rates.

Defibrillator 40

Defibrillator Sudden Cardiac Death Outcomes 40

The British Journal of Cardiology

DECEMBER 3, 2024

Protection against the increased risk of sudden cardiac death (SCD) due to ventricular arrhythmias is offered by the implantation of cardiac defibrillators. This is a single-centre retrospective study on the outcomes of all patients who had a transvenous defibrillator implant in 2015.

Defibrillator 40

Defibrillator Sudden Cardiac Death Biomarkers Arrhythmia 40

DAIC

SEPTEMBER 5, 2024

2, 2024 – Medtronic recently shared long-term results from the global Extravascular Implantable Cardioverter Defibrillator (EV ICD) Pivotal Trial, reinforcing the performance and safety of the EV-ICD system. chief medical officer of the Cardiac Rhythm Management business, which is part of the Cardiovascular Portfolio at Medtronic.

Defibrillator 52

Defibrillator Sudden Cardiac Death Quality of Life Tachycardia 52

Journal of Cardiovascular Electrophysiology

NOVEMBER 22, 2024

ABSTRACT Introduction Substernal extravascular defibrillators (EV ICDs) have been shown to be effective and safe for patients at risk of sudden cardiac death, however, there is little evidence around the safety of extracting chronic devices.

Defibrillator 40

Defibrillator Sudden Cardiac Death 40

HeartRhythm

APRIL 30, 2024

The subcutaneous implantable cardioverter defibrillator (S-ICD) has emerged as an alternative to transvenous ICD for the prevention of sudden cardiac death in patients without pacing indications.

Defibrillator 40

Defibrillator Sudden Cardiac Death Outcomes 40

HeartRhythm

APRIL 30, 2024

Implantable cardiac defibrillators (ICDs) are a fundamental therapy used in the prevention of sudden cardiac death (SCD). Contemporary trials have been incorporated into national guidelines to support their use. However, the elderly are usually excluded or not well represented.

Defibrillator 40

Defibrillator Sudden Cardiac Death Heart Failure Outcomes 40

HeartRhythm

APRIL 30, 2024

Hypertrophic cardiomyopathy (HCM) is associated with risk of sudden cardiac death (SCD). Since approval in late 2012, the subcutaneous implantable cardioverter-defibrillator (SICD) has been used as an alternative to the traditional transvenous ICD (TV-ICD) for SCD prevention in HCM.

Defibrillator 40

Defibrillator Sudden Cardiac Death Cardiomyopathy 40

HeartRhythm

APRIL 30, 2024

Wearable cardioverter-defibrillator (WCD) is an alternative option for the prevention of sudden cardiac death in patients at high risk for malignant ventricular arrhythmias.

Defibrillator 40

Defibrillator Sudden Cardiac Death Arrhythmia 40

American College of Cardiology

FEBRUARY 6, 2024

The following are key points to remember from a review article on cardiac implantable electronic devices (CIEDs), which include pacemakers for bradycardia, biventricular pacemakers for heart failure, and implantable cardioverter–defibrillators (ICDs) for the treatment of sudden cardiac death:

Sudden Cardiac Death 56

Sudden Cardiac Death Pacemaker Bradycardia Defibrillator 56

HeartRhythm

JULY 14, 2024

The subcutaneous implantable cardioverter-defibrillator (S-ICD) has emerged as an alternative to transvenous systems for preventing sudden cardiac death. However, concerns have been raised regarding its efficacy and safety in obese individuals.

Defibrillator 40

Defibrillator Sudden Cardiac Death Obesity 40

HeartRhythm

APRIL 30, 2024

The use of implantable cardioverter-defibrillators (ICD) for primary prevention (PP) of sudden cardiac death among select patients with heart failure (HF) is recommended by the HRS, AHA and ACC. However, whether ICDs may be underutilized within a safety-net system has not been studied.

Defibrillator 40

Defibrillator Heart Failure Sudden Cardiac Death 40

HeartRhythm

APRIL 30, 2024

Hypertrophic cardiomyopathy (HCM) is associated with risk of sudden cardiac death (SCD). Since approval in late 2012, the subcutaneous implantable cardioverter-defibrillator (SICD) has been used as an alternative to the traditional transvenous ICD (TV-ICD) for SCD prevention in HCM.

Defibrillator 40

Defibrillator Sudden Cardiac Death Cardiomyopathy 40

HeartRhythm

APRIL 30, 2024

Implantable cardioverter defibrillators (ICD) are used for primary and secondary prevention of sudden cardiac death. In this case, we highlight a unique complication of increased defibrillator shock impedance in a patient with breast implants followed by normalization after breast implant removal.

Defibrillator 40

Defibrillator Sudden Cardiac Death 40

HeartRhythm

APRIL 30, 2024

Subcutaneous implantable cardioverter-defibrillators (S-ICDs) alleviate many issues associated with a transvenous system, while having similar efficacy to transvenous ICDs at preventing sudden cardiac death. However, S-ICDs have higher rates of shocks due to a lack of anti-tachycardia pacing (ATP).

Defibrillator 40

Defibrillator Sudden Cardiac Death Tachycardia 40

HeartRhythm

JULY 15, 2024

Despite the abundance of evidence supporting the use of implantable cardioverter defibrillators (ICDs) for primary prevention of sudden cardiac death (SCD), racial and gender inequities in ICD implantation persist.1,2

Defibrillator 40

Defibrillator Heart Failure Sudden Cardiac Death 40

Ken Grauer, MD

JUNE 27, 2024

C ASE C onclusion: As noted above — today's patient developed cardiac arrest shortly after arrival in the ED. Despite prolonged resuscitation with multiple defibrillation attempts — the patient could not be saved. = Bidirectional VT: Challenges and Solutions ( Almarzuqi et al — Vasc Health Risk Mgmt 18:3997-406, 2022 ).

Blog 161

Blog Cardiac Arrest Sudden Cardiac Death Tachycardia 161

HeartRhythm

APRIL 30, 2024

For the past four decades, implantable cardioverter defibrillator (ICD) therapy has become the standard of care for preventing sudden cardiac death in high-risk individuals. The rate of ICD implantation has risen due to the increasing population age and the growing prevalence of cardiac arrhythmias.

Atrial Fibrillation 40

Atrial Fibrillation Defibrillator Sudden Cardiac Death Tachycardia 40

Heart BMJ

JANUARY 10, 2024

Sudden cardiac death is one of the main causes of mortality in patients with known or occult cardiac disease and is potentially preventable by early resuscitation.

Defibrillator 40

Defibrillator Sudden Cardiac Death Cardiac Arrest Arrhythmia 40

HeartRhythm

MAY 29, 2024

The implantable cardioverter defibrillator (ICD) improves survival in patients at risk of sudden cardiac death (1).

Defibrillator 40

Defibrillator Sudden Cardiac Death Quality of Life Exercise 40

HeartRhythm

SEPTEMBER 4, 2023

Over the course of several decades, the transvenous implantable cardioverter-defibrillator (TV-ICD) has grown to become a safe and effective treatment for the prevention of sudden cardiac death. During this time, there have been numerous iterative refinements to the system and implant technique.

Defibrillator 40

Defibrillator Sudden Cardiac Death Technology 40

Frontiers in Cardiovascular Medicine

MARCH 14, 2024

Background Brugada syndrome (BrS) is a channelopathy that can lead to sudden cardiac death in the absence of structural heart disease. Case We report the case of a 20-year-old man with variants in SCN5A and RyR2 genes who was resuscitated from sudden cardiac death during sleep due to a ventricular fibrillation.

Sudden Cardiac Death 59

Sudden Cardiac Death Coronary Angiogram Laboratory Echocardiogram 59

HeartRhythm

MAY 7, 2024

Implantable cardioverter defibrillator (ICD) prevents sudden cardiac death (SCD) in patients with ischemic cardiomyopathy (ICM). Catheter ablation has been shown to effectively reduce ventricular tachycardia (VT) recurrence, yet its efficacy in patients without an ICD implantation remains uncertain.

Sudden Cardiac Death 45

Sudden Cardiac Death Tachycardia Cardiomyopathy Ablation 45

The American Journal of Cardiology

JANUARY 6, 2024

Publication date: 15 February 2024 Source: The American Journal of Cardiology, Volume 213 Author(s): Mohammed Al-Sadawi, Chad Gier, Michael Tao, Matthew Henriques, Paul Kim, Faisal Aslam, Ibrahim Almasry, Abhijeet Singh, Roger Fan, Eric Rashba

Sudden Cardiac Death 40

Sudden Cardiac Death Heart Failure Defibrillator 40

Open Heart

AUGUST 25, 2023

Background Consensus guidelines support the use of implanted cardioverter-defibrillators (ICD) for primary prevention of sudden cardiac death in patients with either non-ischaemic or ischaemic cardiomyopathy with left ventricular ejection fraction (LVEF) ≤35%.

Defibrillator 52

Defibrillator Sudden Cardiac Death Myocardial Infarction Echocardiogram 52

Journal of Cardiovascular Electrophysiology

FEBRUARY 7, 2024

Progressive decline across periods in mortality rates among patients with implantable cardioverter-defibrillator (ICD). Abstract Introduction Despite advancements in implantable cardioverter-defibrillator (ICD) technology, sudden cardiac death (SCD) remains a persistent public health concern.

Defibrillator 40

Defibrillator Sudden Cardiac Death Tachycardia Public Health 40

HeartRhythm

APRIL 22, 2024

Implantable cardiac defibrillator (ICD) implantation can protect against sudden cardiac death (SCD) after a myocardial infarction. However, improved risk stratification for device requirement is still needed.

Sudden Cardiac Death 40

Sudden Cardiac Death Myocardial Infarction Defibrillator Tachycardia 40

HeartRhythm

APRIL 30, 2024

Predictive factors of benefit from implantation of an implantable cardioverter-defibrillator (ICD) for primary prophylaxis of sudden cardiac death in patients with nonischemic cardiomyopathy (NICM) have not been clarified.

Sudden Cardiac Death 40

Sudden Cardiac Death Cardiomyopathy Defibrillator 40

HeartRhythm

JANUARY 7, 2024

Randomized clinical trials have proven the survival benefit of implantable cardioverter defibrillators (ICDs) in different patient populations.1-3 1-3 Evidence generated by these trials has informed professional guidelines on ICDs for many years.4-6

Sudden Cardiac Death 45

Sudden Cardiac Death Defibrillator Document 45

DAIC

JANUARY 19, 2024

“Since most don’t survive their cardiac arrest, improvements in prediction and prevention are likely to have the most impact at a global level,” Chugh said. The work has extended beyond conventional approaches by also utilizing warning symptoms of impending sudden cardiac death combined with other biological markers. “Dr.

Cardiac Arrest 105

Cardiac Arrest Heart Rhythm Electrophysiology Sudden Cardiac Death 105

HeartRhythm

APRIL 30, 2024

Studies of sudden cardiac death (SCD) risk intend to specify substrate for fatal arrhythmia rescuable by defibrillator but presume cardiac cause. The Postmortem Systematic Investigation of SCD (POST SCD) study showed nearly half of presumed SCDs (pSCDs) are due to non-arrhythmic causes (e.g.,

Sudden Cardiac Death 40

Sudden Cardiac Death Defibrillator Arrhythmia Stroke 40

HeartRhythm

APRIL 30, 2024

The extravascular implantable cardioverter defibrillator (EV ICD) provides a new option to treat sudden cardiac death using a substernal lead. In some scenarios, these discriminators may demonstrate improvement over TV ICDs.

Sudden Cardiac Death 40

Sudden Cardiac Death Defibrillator 40